IBD serology was positive for anti‐OmpC IgA, IBD‐specific pANCA, and ASCA IgA; and genetic mutations in ATG16L1, ECM1, and NKX2‐3 linked to CD were identified. Here, ATG16L1 is linked to inflammatory bowel disease.